COVID-19
PRODUCT SEARCH
REPORTING OF SIDE EFFECTS TO MEDICINES OR VACCINES
NPRA mission
NPRA mission is to safeguard the nation’s health through scientific excellence in the regulatory control of medicinal products and cosmetics.
Moxifloxacin: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Fixed-Drug Eruption (FDE), and Photosensitivity Associated with Systemic Use |
Directives & Circulars (GCP & GLP) |
Sunitinib: Risk of Hyperammonaemic Encephalopathy |
Official Launch of the NPRA GCP, GLP, BE & EC Inspection Dashboard |
Senarai Produk Tidak Berdaftar/Berdaftar Tetapi Tidak Dipasarkan Dengan Bilangan Permohonan Ubat Kelulusan Khas (UKK) Tertinggi Bagi Tahun 2025 |
| 04 Sep 2025; 08:00AM - 05:00PM Bengkel Pengujian Kawalan Kualiti Bahan Mentah Herba Bagi Produk Semulajadi |





































